Bioelectronics Corp (BIEL) 0.0010 $BIEL
Small Healthcare Companies Sometimes Forgotten
PR Newswire - Fri May 27, 9:10AM CDT
The healthcare sector is large and diverse, with biotechs, drug manufacturers, health insurance companies all falling under its umbrella. A rather overlooked sector are the very small healthcare companies. While not often talked about, these healthcare companies are still trying to prove themselves. The United States is by far the largest consumer of the healthcare market in the world. Advanced Medical Isotope Corp. (OTC: ADMD), Nutranomics Inc. (OTC: NNRX), KollagenX Corp. (OTCQB: KGNX), Bioelectronics Corp (OTC: BIEL)
BioElectronics Engages Adam Staelin As Executive Vice President of Sales and Marketing
PR Newswire - Wed May 11, 7:37AM CDT
BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer pain management medical devices, today announced that it has engaged Adam Staelin as the Executive Vice President of Sales and Marketing.
BioElectronics Responds to U.S. FDA's Comments on its Market Clearance Application
PR Newswire - Tue May 10, 7:37AM CDT
BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced medical devices, announced that it remains in negotiations with the U.S. Food and Drug Administration ("FDA"
regarding its 510(k) premarket notification for the ActiPatch® Musculoskeletal Pain Therapy. Two weeks ago, it submitted detailed responses to the FDA's questions related to the published clinical trials and the Company's Registry Study of the 5,000 UK ActiPatch users. "We responded to all of the FDA's questions from its review of our 510(k) submission and we are hopeful that we satisfied the agency's inquiries," said Ian Rawe, Ph.D., Director of Research for BioElectronics.
BioElectronics' Drug-free ActiPatch® Pain Therapy
PR Newswire - Thu Apr 28, 7:30AM CDT
BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced nonprescription $30.00 neuromodulation pain management medical devices, announces that its drug-free ActiPatch® product was noted in the United Kingdom's Express Newspaper Health Section, http://www.express.co.uk/life-style/health/66...ight-agony. The paper has a circulation of 400,000 that will increase the awareness of ActiPatch therapy for arthritis and chronic pain.
BioElectronics' ActiPatch® Chronic Pain Therapy Featured In UK's Leading Daily Mail Newspaper Health Section
PR Newswire - Mon Apr 25, 7:30AM CDT
BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced nonprescription $30.00 neuromodulation pain management medical devices, announces that its ActiPatch® product's were featured in the United Kingdom's leading Daily Mail's Sunday Health Section, http://www.dailymail.co.uk/health/article-355...etics.html. The paper has a circulation of 1.7 million and should increase the awareness of ActiPatch and its benefits for the millions of UK's chronic pain sufferers.
BioElectronics President Interviewed by the StockRadio.com
PR Newswire - Mon Apr 11, 7:30AM CDT
BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced nonprescription $30.00 neuromodulation pain management medical devices, is pleased to release an interview with President, Andy Whelan. The interview can be heard at http://thestockradio.com/andrew-whelan-bioele...-2953.html.
BioElectronics Appoints Evomed as Australian and New Zealand Distributor
PR Newswire - Mon Mar 21, 7:30AM CDT
BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced medical devices announced today that it has appointed Evomed (www.evomed.com.au) as the distributor for ActiPatch® Musculoskeletal Pain Relief Therapy, Allay® Menstrual Pain Relief Therapy and Smart Insole(TM) Heel Pain Relief Therapy in Australia and New Zealand.
BioElectronics Wins "Best OTC Marketing Campaign on a Small Budget"
PR Newswire - Tue Mar 15, 7:30AM CDT
BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced medical devices announced today that the OTC Bulletin, the leading global trade publication for over-the-counter healthcare products, has chosen its ActiPatch® Musculoskeletal Chronic Pain Relief Therapy as the winner for the "Best OTC Marketing Campaign on a Small Budget" award.
MRK: 57.19 (-0.43)
BioElectronics Invited to Present Chronic Pain Patient Observation Study at the British Pain Society Congress
PR Newswire - Wed Mar 09, 7:30AM CST
BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices, announced today that a research abstract featuring ActiPatch® will be presented at the British Pain Society annual scientific meeting being held from May 10-12 in Harrogate, UK https://www.britishpainsociety.org/2016-asm/. The Company will also be exhibiting at the Congress: Booth #42.
BioElectronics' Innovative Chronic Pain Therapy Nominated for "Best OTC Marketing Campaign on a Small Budget"
PR Newswire - Mon Feb 01, 7:30AM CST
BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced medical devices announced today that its ActiPatch® Musculoskeletal Pain Relief Therapy product received an award nomination from the OTC Bulletin, the leading international trade publication for over-the-counter pharmacy products worldwide for "Best OTC Marketing Campaign on a Small Budget".
BioElectronics Announces Publication of Breakthrough Clinical Study for Drug-free Treatment of Chronic Osteoarthritis
PR Newswire - Tue Jan 05, 7:30AM CST
BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced medical devices announced publication of a clinical study demonstrating the efficacy of ActiPatch® Therapy for knee osteoarthritis. This study further validates the positive effects of negating chronic pain central sensitization1 by ActiPatch® noninvasive neuromodulation therapy. The technology is affordable, effective, and a safe alternative to prescription opioid therapy that is drastically needed in the US and by the 1.5 billion worldwide chronic pain sufferers.
BioElectronics Announces Oxford University Sponsored Study
PR Newswire - Mon Dec 14, 7:30AM CST
BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices, today announced that Oxford University is sponsoring a clinical trial on chronic lower back pain using ActiPatch® Therapy. Chronic low back pain is a major health problem and has significant associated healthcare costs, accounting for more than £12 billion in direct and indirect costs every year in the United Kingdom [1].
BioElectronics' ActiPatch® Pain Therapy Available at 102 Showcase Stores in Canada
PR Newswire - Mon Dec 07, 3:30PM CST
BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer pain management medical devices, today announced that its Canadian distributor, Chris-Kelly LLC, has shipped the initial stocking order to Showcase Stores.
BioElectronics' ActiPatch® Pain Therapy Expands Into Costco Canada
PR Newswire - Thu Nov 19, 7:30AM CST
BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer pain management medical devices, today announced that its Canadian distributor has received its initial orders for its ActiPatch® Pain Relief products from Costco's online store, http://www.costco.ca/CatalogSearch?storeId=10...=actipatch.
Penny Stocks Alerts for Dominovas Energy, Agrieuro, Magnum Hunter Resources, Bioelectronics, EKSO BIONICS, and Premier Biomedical
PR Newswire - Wed Nov 18, 8:00AM CST
Pennystocksinsiders.com (PSI) released FREE insider trading reports for US market investors to track the following active stocks and penny stocks: Dominovas Energy (OTCMKTS: DNRG), Agrieuro (OTCBB: EURI), Magnum Hunter Resources (OTCMKTS: MHRC), Bioelectronics (OTCMKTS: BIEL), EKSO BIONICS (OTCBB: EKSO), and Premier Biomedical (OTCMKTS: BIEI).
MHR: 0.15 (-0.11)
Penny Stocks Alerts for HIGH PERFORMANCE, Agrieuro, Bioelectronics, Liquidmetal Technologies, NuGene International, and That Marketing Solution
PR Newswire - Wed Nov 11, 8:00AM CST
Pennystocksinsiders.com (PSI) released FREE insider trading reports for US market investors to track the following active stocks and penny stocks: HIGH PERFORMANCE (OTCMKTS:TBEV), Agrieuro (OTCBB:EURI), Bioelectronics (OTCMKTS:BIEL), Liquidmetal Technologies (OTCMKTS:LQMT), NuGene International (OTCMKTS:NUGN), and That Marketing Solution (OTCMKTS:TSTS).
Trending Small Cap Stocks For Monday November 9, 2015
ACCESSWIRE - Mon Nov 09, 8:49AM CST
CORAL GABLES, FL / ACCESSWIRE / November 9, 2015 / There's no secret that small cap stocks can be some of the most volatile. Catalysts such as market momentum, news, or even social buzz can quickly spark high powered runs. This year the biotech sector has seen this first hand. From medical devices to new drug therapies, speculators and earnings forecasters have reacted to announcements as well as industry rumors with resulting action in the market finding, at time, aggressive bull runs. Companies like BioElectronics Corporation (PINKSHEETS: BIEL), Aeterna Zentaris Inc. (NASDAQ: AEZS), and AgriEuro Corp. (OTCQB: EURI) have seen increases in share price and volume over the last few weeks.
AEZS: 3.50 (-0.02)
BioElectronics Expands in the UK Market
PR Newswire - Mon Nov 09, 6:00AM CST
BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer pain management medical devices, today announced that it has received an initial order for its ActiPatch® Musculoskeletal Pain Relief products from Superdrug pharmacies. Superdrug is a subsidiary of the A.S. Watson Group, the world's largest international health and beauty retailer with 12,000 stores. Superdrug will promote BioElectronics' 7-Day Trial Device, Try & Tell Marketing Campaign online and stock ActiPatch in 186 stores in mid-November.
UpTick Newswire Radio Show Will Interview BioElectronics' CEO Andrew Whelan
Marketwired - Wed Nov 04, 7:01AM CST
BioElectronics Corporation (OTC PINK: BIEL), maker of consumer medical electronics products for pain management, announced that Andrew J. Whelan, President, will be interviewed by Stu Taylor on his program "On Business" at 9am EST on Thursday, November 5th. To listen to the interview live, tune to:
Be On Top Of the Latest Developments - Research on Elite Pharmaceuticals, NanoTech Entertainment, Medbox and Bioelectronics
ACCESSWIRE - Wed Oct 28, 7:00AM CDT
NEW YORK, NY / ACCESSWIRE / October 28, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Elite Pharmaceuticals Inc. (OTC: ELTP), NanoTech Entertainment, Inc. (OTC: NTEK), Medbox Inc. (OTC: MDBX) and Bioelectronics Corp. (OTC: BIEL). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full research reports are being made available to the public on a complimentary basis.
Small Healthcare Companies Sometimes Forgotten
PR Newswire - Fri May 27, 9:10AM CDT
The healthcare sector is large and diverse, with biotechs, drug manufacturers, health insurance companies all falling under its umbrella. A rather overlooked sector are the very small healthcare companies. While not often talked about, these healthcare companies are still trying to prove themselves. The United States is by far the largest consumer of the healthcare market in the world. Advanced Medical Isotope Corp. (OTC: ADMD), Nutranomics Inc. (OTC: NNRX), KollagenX Corp. (OTCQB: KGNX), Bioelectronics Corp (OTC: BIEL)
BioElectronics Engages Adam Staelin As Executive Vice President of Sales and Marketing
PR Newswire - Wed May 11, 7:37AM CDT
BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer pain management medical devices, today announced that it has engaged Adam Staelin as the Executive Vice President of Sales and Marketing.
BioElectronics Responds to U.S. FDA's Comments on its Market Clearance Application
PR Newswire - Tue May 10, 7:37AM CDT
BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced medical devices, announced that it remains in negotiations with the U.S. Food and Drug Administration ("FDA"
regarding its 510(k) premarket notification for the ActiPatch® Musculoskeletal Pain Therapy. Two weeks ago, it submitted detailed responses to the FDA's questions related to the published clinical trials and the Company's Registry Study of the 5,000 UK ActiPatch users. "We responded to all of the FDA's questions from its review of our 510(k) submission and we are hopeful that we satisfied the agency's inquiries," said Ian Rawe, Ph.D., Director of Research for BioElectronics. BioElectronics' Drug-free ActiPatch® Pain Therapy
PR Newswire - Thu Apr 28, 7:30AM CDT
BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced nonprescription $30.00 neuromodulation pain management medical devices, announces that its drug-free ActiPatch® product was noted in the United Kingdom's Express Newspaper Health Section, http://www.express.co.uk/life-style/health/66...ight-agony. The paper has a circulation of 400,000 that will increase the awareness of ActiPatch therapy for arthritis and chronic pain.
BioElectronics' ActiPatch® Chronic Pain Therapy Featured In UK's Leading Daily Mail Newspaper Health Section
PR Newswire - Mon Apr 25, 7:30AM CDT
BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced nonprescription $30.00 neuromodulation pain management medical devices, announces that its ActiPatch® product's were featured in the United Kingdom's leading Daily Mail's Sunday Health Section, http://www.dailymail.co.uk/health/article-355...etics.html. The paper has a circulation of 1.7 million and should increase the awareness of ActiPatch and its benefits for the millions of UK's chronic pain sufferers.
BioElectronics President Interviewed by the StockRadio.com
PR Newswire - Mon Apr 11, 7:30AM CDT
BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced nonprescription $30.00 neuromodulation pain management medical devices, is pleased to release an interview with President, Andy Whelan. The interview can be heard at http://thestockradio.com/andrew-whelan-bioele...-2953.html.
BioElectronics Appoints Evomed as Australian and New Zealand Distributor
PR Newswire - Mon Mar 21, 7:30AM CDT
BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced medical devices announced today that it has appointed Evomed (www.evomed.com.au) as the distributor for ActiPatch® Musculoskeletal Pain Relief Therapy, Allay® Menstrual Pain Relief Therapy and Smart Insole(TM) Heel Pain Relief Therapy in Australia and New Zealand.
BioElectronics Wins "Best OTC Marketing Campaign on a Small Budget"
PR Newswire - Tue Mar 15, 7:30AM CDT
BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced medical devices announced today that the OTC Bulletin, the leading global trade publication for over-the-counter healthcare products, has chosen its ActiPatch® Musculoskeletal Chronic Pain Relief Therapy as the winner for the "Best OTC Marketing Campaign on a Small Budget" award.
MRK: 57.19 (-0.43)
BioElectronics Invited to Present Chronic Pain Patient Observation Study at the British Pain Society Congress
PR Newswire - Wed Mar 09, 7:30AM CST
BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices, announced today that a research abstract featuring ActiPatch® will be presented at the British Pain Society annual scientific meeting being held from May 10-12 in Harrogate, UK https://www.britishpainsociety.org/2016-asm/. The Company will also be exhibiting at the Congress: Booth #42.
BioElectronics' Innovative Chronic Pain Therapy Nominated for "Best OTC Marketing Campaign on a Small Budget"
PR Newswire - Mon Feb 01, 7:30AM CST
BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced medical devices announced today that its ActiPatch® Musculoskeletal Pain Relief Therapy product received an award nomination from the OTC Bulletin, the leading international trade publication for over-the-counter pharmacy products worldwide for "Best OTC Marketing Campaign on a Small Budget".
BioElectronics Announces Publication of Breakthrough Clinical Study for Drug-free Treatment of Chronic Osteoarthritis
PR Newswire - Tue Jan 05, 7:30AM CST
BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced medical devices announced publication of a clinical study demonstrating the efficacy of ActiPatch® Therapy for knee osteoarthritis. This study further validates the positive effects of negating chronic pain central sensitization1 by ActiPatch® noninvasive neuromodulation therapy. The technology is affordable, effective, and a safe alternative to prescription opioid therapy that is drastically needed in the US and by the 1.5 billion worldwide chronic pain sufferers.
BioElectronics Announces Oxford University Sponsored Study
PR Newswire - Mon Dec 14, 7:30AM CST
BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices, today announced that Oxford University is sponsoring a clinical trial on chronic lower back pain using ActiPatch® Therapy. Chronic low back pain is a major health problem and has significant associated healthcare costs, accounting for more than £12 billion in direct and indirect costs every year in the United Kingdom [1].
BioElectronics' ActiPatch® Pain Therapy Available at 102 Showcase Stores in Canada
PR Newswire - Mon Dec 07, 3:30PM CST
BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer pain management medical devices, today announced that its Canadian distributor, Chris-Kelly LLC, has shipped the initial stocking order to Showcase Stores.
BioElectronics' ActiPatch® Pain Therapy Expands Into Costco Canada
PR Newswire - Thu Nov 19, 7:30AM CST
BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer pain management medical devices, today announced that its Canadian distributor has received its initial orders for its ActiPatch® Pain Relief products from Costco's online store, http://www.costco.ca/CatalogSearch?storeId=10...=actipatch.
Penny Stocks Alerts for Dominovas Energy, Agrieuro, Magnum Hunter Resources, Bioelectronics, EKSO BIONICS, and Premier Biomedical
PR Newswire - Wed Nov 18, 8:00AM CST
Pennystocksinsiders.com (PSI) released FREE insider trading reports for US market investors to track the following active stocks and penny stocks: Dominovas Energy (OTCMKTS: DNRG), Agrieuro (OTCBB: EURI), Magnum Hunter Resources (OTCMKTS: MHRC), Bioelectronics (OTCMKTS: BIEL), EKSO BIONICS (OTCBB: EKSO), and Premier Biomedical (OTCMKTS: BIEI).
MHR: 0.15 (-0.11)
Penny Stocks Alerts for HIGH PERFORMANCE, Agrieuro, Bioelectronics, Liquidmetal Technologies, NuGene International, and That Marketing Solution
PR Newswire - Wed Nov 11, 8:00AM CST
Pennystocksinsiders.com (PSI) released FREE insider trading reports for US market investors to track the following active stocks and penny stocks: HIGH PERFORMANCE (OTCMKTS:TBEV), Agrieuro (OTCBB:EURI), Bioelectronics (OTCMKTS:BIEL), Liquidmetal Technologies (OTCMKTS:LQMT), NuGene International (OTCMKTS:NUGN), and That Marketing Solution (OTCMKTS:TSTS).
Trending Small Cap Stocks For Monday November 9, 2015
ACCESSWIRE - Mon Nov 09, 8:49AM CST
CORAL GABLES, FL / ACCESSWIRE / November 9, 2015 / There's no secret that small cap stocks can be some of the most volatile. Catalysts such as market momentum, news, or even social buzz can quickly spark high powered runs. This year the biotech sector has seen this first hand. From medical devices to new drug therapies, speculators and earnings forecasters have reacted to announcements as well as industry rumors with resulting action in the market finding, at time, aggressive bull runs. Companies like BioElectronics Corporation (PINKSHEETS: BIEL), Aeterna Zentaris Inc. (NASDAQ: AEZS), and AgriEuro Corp. (OTCQB: EURI) have seen increases in share price and volume over the last few weeks.
AEZS: 3.50 (-0.02)
BioElectronics Expands in the UK Market
PR Newswire - Mon Nov 09, 6:00AM CST
BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer pain management medical devices, today announced that it has received an initial order for its ActiPatch® Musculoskeletal Pain Relief products from Superdrug pharmacies. Superdrug is a subsidiary of the A.S. Watson Group, the world's largest international health and beauty retailer with 12,000 stores. Superdrug will promote BioElectronics' 7-Day Trial Device, Try & Tell Marketing Campaign online and stock ActiPatch in 186 stores in mid-November.
UpTick Newswire Radio Show Will Interview BioElectronics' CEO Andrew Whelan
Marketwired - Wed Nov 04, 7:01AM CST
BioElectronics Corporation (OTC PINK: BIEL), maker of consumer medical electronics products for pain management, announced that Andrew J. Whelan, President, will be interviewed by Stu Taylor on his program "On Business" at 9am EST on Thursday, November 5th. To listen to the interview live, tune to:
Be On Top Of the Latest Developments - Research on Elite Pharmaceuticals, NanoTech Entertainment, Medbox and Bioelectronics
ACCESSWIRE - Wed Oct 28, 7:00AM CDT
NEW YORK, NY / ACCESSWIRE / October 28, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Elite Pharmaceuticals Inc. (OTC: ELTP), NanoTech Entertainment, Inc. (OTC: NTEK), Medbox Inc. (OTC: MDBX) and Bioelectronics Corp. (OTC: BIEL). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full research reports are being made available to the public on a complimentary basis.
